(Q51965402)

19 April 2018

title

Quality-of-life differences between patients with episodic and transformed migraine. (English)

1 reference

19 April 2018

0 references

1 reference

1 reference

Meletiche DM

1

1 reference

19 April 2018

Lofland JH

series ordinal

2

1 reference

19 April 2018

Young WB

series ordinal

3

1 reference

19 April 2018

publication date

1 June 2001

1 reference

19 April 2018

published in

Headache

1 reference

19 April 2018

volume

41

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

page(s)

573-578

1 reference

19 April 2018

The prevalence and characteristics of migraine in a population-based cohort: the GEM study

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Burden of migraine: societal costs and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Measuring the functional status and well-being of patients with migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Improvement in migraine-specific quality of life in a clinical trial of rizatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Prevalence of frequent headache in a population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Kaplan Award 1998. Epidemiology of chronic daily headache in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Quality of life in migraine and chronic daily headache patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Does quality of life differ among headache diagnoses? Analysis using the medical outcomes study instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

21 January 2018

Transformed migraine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Classification of daily and near-daily headaches: proposed revisions to the IHS criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Loss of productivity and quality of life in migraine sufferers among French workers: results from the GAZEL cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Sumatriptan and lost productivity time: a time series analysis of diary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

Burden of migraine. A review of its socioeconomic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.041006573.X

10.1046/J.1526-4610.2001.041006573.X

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018